Fosun Pharma's Subsidiary Gains Approval for Shaoyao Gancao Tang Granules

Stock News06-29 17:58

Shanghai Fosun Pharmaceutical (Group) Co.,Ltd. (600196.SH) has announced that its subsidiary, Hebei Wanbang Fulin Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the drug registration application of Shaoyao Gancao Tang Granules.

The prescription for this medication originates from the classical text "Treatise on Cold Damage Diseases" by Zhang Zhongjing of the Han Dynasty and is included in the National Administration of Traditional Chinese Medicine's "Catalogue of Ancient Classical Famous Prescriptions (First Batch)."

Its primary functions are to nourish yin and blood, and to relieve spasms and pain. It is indicated for conditions involving spasmodic pain due to insufficient yin and blood and malnourishment of tendons and vessels, with symptoms such as cramps in the legs and feet and abdominal pain.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1196896333?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-29 17:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1196896333","market":"sg","top_or_hot":-1,"title":"Fosun Pharma's Subsidiary Gains Approval for Shaoyao Gancao Tang Granules","media":"Stock News","content":"<p><b>Shanghai Fosun Pharmaceutical (Group) Co.,Ltd.</b> (<b>600196.SH</b>) has announced that its subsidiary, Hebei Wanbang Fulin Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the drug registration application of Shaoyao Gancao Tang Granules.<br><br>The prescription for this medication originates from the classical text \"Treatise on Cold Damage Diseases\" by Zhang Zhongjing of the Han Dynasty and is included in the National Administration of Traditional Chinese Medicine's \"Catalogue of Ancient Classical Famous Prescriptions (First Batch).\"<br><br>Its primary functions are to nourish yin and blood, and to relieve spasms and pain. It is indicated for conditions involving spasmodic pain due to insufficient yin and blood and malnourishment of tendons and vessels, with symptoms such as cramps in the legs and feet and abdominal pain.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fosun Pharma's Subsidiary Gains Approval for Shaoyao Gancao Tang Granules</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFosun Pharma's Subsidiary Gains Approval for Shaoyao Gancao Tang Granules\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-29 17:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Shanghai Fosun Pharmaceutical (Group) Co.,Ltd.</b> (<b>600196.SH</b>) has announced that its subsidiary, Hebei Wanbang Fulin Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the drug registration application of Shaoyao Gancao Tang Granules.<br><br>The prescription for this medication originates from the classical text \"Treatise on Cold Damage Diseases\" by Zhang Zhongjing of the Han Dynasty and is included in the National Administration of Traditional Chinese Medicine's \"Catalogue of Ancient Classical Famous Prescriptions (First Batch).\"<br><br>Its primary functions are to nourish yin and blood, and to relieve spasms and pain. It is indicated for conditions involving spasmodic pain due to insufficient yin and blood and malnourishment of tendons and vessels, with symptoms such as cramps in the legs and feet and abdominal pain.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0187","symbol_name":"一线龙头","start_time":0,"source_url":"","article_id":"1196896333","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1196896333","pubTimestamp":1782727131,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Shanghai Fosun Pharmaceutical (Group) Co.,Ltd. (600196.SH) has announced that its subsidiary, Hebei Wanbang Fulin Pharmaceutical Co., Ltd., has received approval from the National Medical Products...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600196":"复星医药","BK0187":"一线龙头","BK0060":"抗癌","BK0028":"国家队","02196":"复星医药","BK0239":"医药制造","BK0183":"MSCI概念","BK1191":"制药","BK1515":"抗疫概念","BK1593":"医美概念股","BK0175":"白马股","BK0188":"融资融券","BK0096":"民营医院","BK0012":"证金概念","BK0196":"行业龙头"},"translate_title":"复星医药子公司芍药甘草汤颗粒获批","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600196":1,"02196":1},"content_text":"Shanghai Fosun Pharmaceutical (Group) Co.,Ltd. (600196.SH) has announced that its subsidiary, Hebei Wanbang Fulin Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the drug registration application of Shaoyao Gancao Tang Granules.The prescription for this medication originates from the classical text \"Treatise on Cold Damage Diseases\" by Zhang Zhongjing of the Han Dynasty and is included in the National Administration of Traditional Chinese Medicine's \"Catalogue of Ancient Classical Famous Prescriptions (First Batch).\"Its primary functions are to nourish yin and blood, and to relieve spasms and pain. It is indicated for conditions involving spasmodic pain due to insufficient yin and blood and malnourishment of tendons and vessels, with symptoms such as cramps in the legs and feet and abdominal pain.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1196896333","isCrawlerRequest":true}